As increasing regulatory and scientific complexities threaten R&D productivity, you need a bioanalytical laboratory services partner who can truly enhance the drug development process.
We use our 20+ years of experience to understand the unique challenges faced by our customers today. Our extensive capabilities include LC/MS services, immunoassay services, fit-for-purpose biomarker services, and in vitro ADME assays and metabolite identification services.
Download our bioanalytical and ADME services brochure to learn how IQVIA Laboratories can help you with a full range of ADME and bioanalytical services, from high-throughput ADME screening to immunogenicity testing.
Download Document
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Hybrid Assays for Protein Bioanalysis
Assays and Why Are They Essential for Protein Bioanalysis?
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
High Throughput ADME Testing
Minimizing turnaround time for ADME assays
ADME Services
Accelerating your drug discovery, preclinical and clinical programs with ADME services
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
Early Hit-to-Lead ADME Screening Bundle
Bundled Screening Assays to Accelerate Candidate Selection in Drug Discovery
High Throughput ADME Screening Services
Capabilities that accelerate preclinical studies
IND-Enabling Bundle of In Vitro Assays to Assess Drug-Drug Interaction Risk
DDI Fact Sheet
